Healthy Debate
  • Search
  • Health topics
  • Debates
  • Special Series
  • All topics
  • All articles
Most popular today
  • Environment (53)
  • Mental Health (244)
  • Social Determinants (408)
  • Public Health (685)
  • Addiction (135)
  • Anxiety (9)
  • Prevention (260)
  • Primary Care (502)
  • COVID-19 (539)
  • Health Infrastructure (967)
  • Research (147)
  • Policy and Politics (1019)
  • Alcohol (21)
  • Education (276)
  • Infectious Disease (635)
  • Lived Experience (378)
  • Women's Health (151)
  • Aging (178)
  • Other conditions (266)
  • Nutrition (78)
  • Technology and Innovation (242)
  • Children and Youth (239)
  • Obesity (29)
  • Long-Term Care (71)
  • About
  • Subscribe

Pharmaceutical Policy

Trump loosening FDA regulations could hurt Canadians

Seema Marwaha | March 15, 2017
Joel Lexchin

The pharmaceutical advertising code should be updated

Seema Marwaha | August 10, 2016
Joel Lexchin and Barbara Mintzes

Donate to Healthy Debate

Your support allows us to publish journalism about healthcare in Canada that is free to read and free to republish. Donations are tax-deductible.

Donate

Join the mailing list

Sign up below to receive our newsletter every Thursday morning.

You can republish our articles online or in print for free. Read more.

Republish us
  • About
  • Contribute
  • Contact
  • Community Guidelines
  • Terms & Conditions
  • Privacy Policy

Republish this article

  1. Please use the invisible republishing code below on the page where you republish this article.
  2. Please give credit to Healthy Debate and include a link back to our home page or the article URL . Our preference is a credit at the top of the article and that you include our logo  (available by clicking the link below).

Please read the full set of instructions for republication here.